December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Baxter International (NY:BAX)

22.88 -0.62 (-2.64%)
Delayed Quote Updated: 3:26 PM EDT, Oct 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Baxter International

< Previous 1 2
...
22 23 24 25 26 27 28 29 Next >
News headline image
Baxter Highlights New Data Indicating Sharesource Digital Health Platform for Home Dialysis May Improve Survival and Reduce Hospitalizations
From Baxter International Inc.
Via Business Wire
News headline image
Baxter to Present at Evercore ISI 4th Annual HealthCONx Conference
From Baxter International Inc.
Via Business Wire
News headline image
Baxter International Inc (BAX) Q2 2021 Earnings Call Transcript ↗
BAX earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Baxter Shares Fall Despite Better-Than-Expected Q3 Earnings, FY21 EPS Outlook Boost ↗
Baxter International Inc (NYSE: BAX) posted Q3 revenue of $3.23 billion, in line with the consensus, up 9% on a reported basis, 7% on a constant currency basis, and 6%... 
Via Benzinga
News headline image
Stock Profile: Baxter International Inc. ↗
Baxter International reported second-quarter sales increased a healthy 14% to $3.1 billion with net income increasing 22% to $301 million and EPS jumping 23% to $0.59. 
Via Talk Markets
News headline image
The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Corvus' China Partner Approved For Early Stage Study Of CPI-818 In... 
Via Benzinga
News headline image
Baxter Reports Third-Quarter 2021 Results
From Baxter International Inc.
Via Business Wire
News headline image
Baxter and bioMérieux Announce CE Mark for NEPHROCLEAR™ CCL14 Test to Predict Persistent Severe Acute Kidney Injury
From Baxter International Inc. and bioMérieux
Via Business Wire
News headline image
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More ↗
Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength... 
Via Benzinga
News headline image
Baxter to Present at Credit Suisse 30th Annual Virtual Healthcare Conference
From Baxter International Inc.
Via Business Wire
News headline image
Baxter Presents Critical Care Data at 34th Annual European Society of Intensive Care Medicine LIVES Congress
From Baxter International Inc.
Via Business Wire
News headline image
Baxter to Host Third-Quarter 2021 Financial Results Conference Call for Investors
From Baxter International Inc.
Via Business Wire
News headline image
Baxter's Norepinephrine Wins FDA Nod For Low Blood Pressure ↗
The FDA has approved Baxter International Inc's (NYSE: BAX) premix norepinephrine bitartrate in 5% dextrose injection. Norepinephrine is indicated to raise blood pressure in... 
Via Benzinga
News headline image
Baxter Announces U.S. FDA Approval and Launch of Ready-to-use Cardiovascular Medicine Norepinephrine in Premix Formulation
From Baxter International Inc.
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2021 ↗
Upgrades For Bank of America Corp (NYSE: 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 3, 2021 ↗
Upgrades Barclays upgraded the previous rating for Baxter International Inc (NYSE: 
Via Benzinga
News headline image
Price To Earnings Ratio Insights For Baxter Intl ↗
Looking into the current session, Baxter Intl Inc. (NYSE:BAX) shares are trading at $82.22, after a 5.95% rise. Moreover, over the past month, the stock spiked by 10... 
Via Benzinga
News headline image
Baxter to Acquire Hillrom At $156/Share: See The Highlights ↗
Baxter International Inc (NYSE: BAX) has agreed to acquire Hill-Rom Holdings Inc (NYSE: HRC) for $156.00 per share in cash, slightly higher than the earlier... 
Via Benzinga
News headline image
Baxter to Acquire Hillrom, Expanding Connected Care and Medical Innovation Globally
From Baxter International Inc.
Via Business Wire
News headline image
2 Little-Followed Stocks That Are Soaring Monday ↗
Markets were on the rise overall, but these companies were surprising in their gains. 
Via The Motley Fool
Topics Stocks
News headline image
Why Shares of Hill-Rom Holdings Are Surging This Morning ↗
A previous buyout offer gets raised. 
Via The Motley Fool
News headline image
Baxter In Advanced Talks For $10B Hill Rom Buyout: WSJ ↗
The Wall Street Journal reported that Baxter International Inc (NYSE: BAX) is reportedly in advanced talks to Hill-Rom Holdings Inc (NYSE: HRC) for... 
Via Benzinga
News headline image
Baxter International Inc (BAX) Under Pressure, Here’s The Trade ↗
Baxter International Inc stock is now trading below its 200-week moving average. This puts the stock in a weak technical position on the charts and indicates lower stock prices ahead. 
Via Talk Markets
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
During Thursday's morning session, 21 companies made new 52-week lows. Interesting Highlights: Baxter Intl (NYSE:BAX) was the largest company by market cap to... 
Via Benzinga
News headline image
The Baxter International Foundation and UNICEF USA Announce Partnership to Improve Water Security in Colombia
From Baxter International Inc.
Via Business Wire
News headline image
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (... 
Via Benzinga
News headline image
Baxter Recalls Dose IQ Software 9.0.x Used With Infusion Pumps ↗
The FDA issued a Class I recall, the most serious kind of recall, for Baxter International Inc's (NYSE: BAX) Dose IQ safety software used with Spectrum IQ... 
Via Benzinga
Topics Product Recall
News headline image
Got $5,000? These 3 Solid Dividend Stocks Are Trading Near Their 52-Week Lows ↗
If you're an income investor, these investments should be on your radar right now. 
Via The Motley Fool
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
During Thursday's morning session, 77 companies made new 52-week lows. Areas of Interest: The largest company in terms of market cap to set a new 52-week low... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)... 
Via Benzinga
< Previous 1 2
...
22 23 24 25 26 27 28 29 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.